RecruitingPhase 2NCT04546399
Rare condition
Congenital Epstein-Barr virus infection
4
studies recruiting now
as of 7 Sept 2026
193
studies registered in total
as of 7 Sept 2026
4
countries with a recruiting site
as of 7 Sept 2026
14 Sept 2020
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT01137825
Registry of Older Patients With Cancer
RecruitingNCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
RecruitingPhase 2NCT03266653
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Showing the 4 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
Search all Congenital Epstein-Barr virus infection studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Congenital Epstein-Barr virus infection study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Congenital Epstein-Barr virus infection
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
5 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Lenalidomide (Lenalidomide accord)
Phase 2Rituximab (Blitzima)
Phase 1Traxivitug
Phase 114g2a
Phase 1 (early)Toripalimab (Loqtorzi)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).